Protective cross-reactive cellular immunity to lethal A/Goose/Guangdong/1/96-like H5N1 influenza virus is correlated with the proportion of pulmonary CD8(+) T cells expressing gamma interferon.
about
Susceptibility of Canada Geese (Branta canadensis) to highly pathogenic avian influenza virus (H5N1)H5N1 outbreaks and enzootic influenzaHeterosubtypic T-Cell Immunity to Influenza in Humans: Challenges for Universal T-Cell Influenza VaccinesBroad-Spectrum Drugs Against Viral AgentsA pandemic influenza H1N1 live vaccine based on modified vaccinia Ankara is highly immunogenic and protects mice in active and passive immunizationsInfluenza virus in a natural host, the mallard: experimental infection dataPrevalence of antibodies against seasonal influenza A and B viruses during the 2009-2010 and 2010-2011 influenza seasons in residents of Pittsburgh, PA, USAEcological and immunological determinants of influenza evolution.Cell-mediated protection in influenza infection.Cross-protective immunity against influenza A/H1N1 virus challenge in mice immunized with recombinant vaccine expressing HA gene of influenza A/H5N1 virus.Characterization of avian H9N2 influenza viruses from United Arab Emirates 2000 to 2003Vaccination against human influenza A/H3N2 virus prevents the induction of heterosubtypic immunity against lethal infection with avian influenza A/H5N1 virus.Biopolymer encapsulated live influenza virus as a universal CD8+ T cell vaccine against influenza virus.Induction of virus-specific cytotoxic T lymphocytes as a basis for the development of broadly protective influenza vaccinesPredominance of heterosubtypic IFN-γ-only-secreting effector memory T cells in pandemic H1N1 naive adults.The design and proof of concept for a CD8(+) T cell-based vaccine inducing cross-subtype protection against influenza A virus.Identification of a dual-specific T cell epitope of the hemagglutinin antigen of an h5 avian influenza virus in chickens.Homo- and heterosubtypic low pathogenic avian influenza exposure on H5N1 highly pathogenic avian influenza virus infection in wood ducks (Aix sponsa)Global patterns of influenza a virus in wild birds.Cross-protective peptide vaccine against influenza A viruses developed in HLA-A*2402 human immunity model.Nucleotide oligomerization and binding domain 2-dependent dendritic cell activation is necessary for innate immunity and optimal CD8+ T Cell responses to influenza A virus infectionLethal H5N1 influenza viruses escape host anti-viral cytokine responses.Identification of novel avian influenza virus derived CD8+ T-cell epitopesInduction of CD8 T cell heterologous protection by a single dose of single-cycle infectious influenza virus.Influenza, immune system, and pregnancyHeterosubtypic immunity to influenza A virus infections in mallards may explain existence of multiple virus subtypesAn infected chicken kidney cell co-culture ELISpot for enhanced detection of T cell responses to avian influenza and vaccinationThe contribution of systemic and pulmonary immune effectors to vaccine-induced protection from H5N1 influenza virus infection.Avian influenza virus: prospects for prevention and control by vaccination.Influenza and the challenge for immunology.Effects of NS1 variants of H5N1 influenza virus on interferon induction, TNFalpha response and p53 activityInduction of respiratory immune responses in the chicken; implications for development of mucosal avian influenza virus vaccines.Non-replicating adenovirus vectors expressing avian influenza virus hemagglutinin and nucleocapsid proteins induce chicken specific effector, memory and effector memory CD8(+) T lymphocytes.The makings of a killer.Induction of cytotoxic T-lymphocyte and antibody responses against highly pathogenic avian influenza virus infection in mice by inoculation of apathogenic H5N1 influenza virus particles inactivated with formalin.Protective role of γδ T cells in cigarette smoke and influenza infection.The CD8 T Cell Response to Respiratory Virus Infections.Use of Toll-Like Receptor 3 Agonists Against Respiratory Viral Infections.Persistence and transmission of avian influenza A (H5N1): virus movement, risk factors and pandemic potential
P2860
Q24606400-5EE87F30-3A74-429F-B5EC-FFDDE2E1CF96Q24628500-349C7EA2-9DAE-42FF-A259-88055D6BB1C7Q26744622-91CF78E9-AEEB-4F33-9E13-67FFC6C3B08CQ27487859-CBA9FB10-6E0D-4730-9B31-5005D434D911Q28749671-DA31120E-FAA5-4053-8ECA-2E0FA6671423Q30000979-8C9D510E-96B2-4AF6-8D93-0A5CF96A8DD5Q30224919-0058C910-4A13-4427-8552-E8FE76204EBEQ30332657-54F15F1E-F942-4573-95A0-3B22B083D1A4Q30353071-3B6F59E9-A2D6-4B61-A8CA-5C8345E14283Q30353786-8FD04952-6742-41CF-BD2B-3CF6F21BD069Q30358664-65FEEDA9-8482-47D5-96F5-F4DD3AE1252DQ30377041-BFE97E94-F5EC-4FF6-A3A4-3B9CAD8F4095Q30395580-2E3E957E-21CC-4967-8EEA-82FCB24503E0Q30408295-A81BEE3F-4307-43AC-A0BD-8446D91144DDQ30418993-4F997C4C-BAB5-4BFC-BC8D-D72AC7EB5000Q30423530-053C1555-2658-4F2C-90D3-4F6C26F33F06Q30879279-11797082-DC86-4DAE-BF9F-553BE1C292A0Q33799251-AE795E3D-AE1A-4FB1-BA50-075F55229F8DQ33995214-75017D8C-F255-4A9A-9F75-72F6E27A4E13Q34031410-B2089BC1-41B5-4C5B-8D82-39E0787A65E3Q34059098-7C2AEBB3-F3BF-41E3-AE43-F1580E776C5EQ34146021-3593FD7D-150D-4723-85FC-601200AF6F7FQ34182121-96EF63BB-8A18-49B9-B236-AE4AAD8640CAQ34261441-56856DAF-2D68-4F5F-8DE8-FEB06AEFF78EQ34506733-711A3A7A-7C3C-41F9-8E81-B9FD2CA8B2DDQ34789297-726B718A-014C-4FDE-8302-466BFEE24A5EQ35100228-FA9C1885-FC68-40C8-9429-07FAC04570B8Q35943771-631C58C8-B018-4BB5-A7C3-267C435FD885Q36257820-651E7BCF-8C2F-443F-B059-798914781D4FQ36452600-23DA533D-DDAE-49D4-977A-879A47DB9AFFQ37729128-6A8CB390-6AE2-4D89-ACF8-814DD97EB245Q38031950-A2063A8B-4D50-4BB4-B259-2FDE051E3C3BQ42451182-02C0983E-6C74-4433-A251-DEF0719B8174Q43209699-186D1812-3D31-491C-A7B3-D9B4C7FCD658Q45397691-74EA03B5-CD6A-4234-81B9-5FA8AE763720Q46748313-CE9CFD72-1987-4B67-85AC-05FE31DC4868Q55101403-643D131F-9F7D-4C7A-9C9B-47A5B888E1F3Q55379440-5C210D55-30F6-4302-9619-78D664EC731BQ58301484-652B1A1F-A8D7-4F90-9A9A-D9AE010B5091
P2860
Protective cross-reactive cellular immunity to lethal A/Goose/Guangdong/1/96-like H5N1 influenza virus is correlated with the proportion of pulmonary CD8(+) T cells expressing gamma interferon.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Protective cross-reactive cell ...... he proportion of pulmonary CD8
@nl
Protective cross-reactive cell ...... s expressing gamma interferon.
@en
type
label
Protective cross-reactive cell ...... he proportion of pulmonary CD8
@nl
Protective cross-reactive cell ...... s expressing gamma interferon.
@en
prefLabel
Protective cross-reactive cell ...... he proportion of pulmonary CD8
@nl
Protective cross-reactive cell ...... s expressing gamma interferon.
@en
P2860
P1433
P1476
Protective cross-reactive cell ...... s expressing gamma interferon.
@en
P2093
Malik Peiris
Sang Heui Seo
P2860
P304
P356
10.1128/JVI.76.10.4886-4890.2002
P407
P577
2002-05-01T00:00:00Z